Oruka Therapeutics director Kristine Ball sells $1.89M stock
On November 12, 2026, Kristine M. Ball, a director at Oruka Therapeutics, Inc., sold 17,990 shares of the company's common stock. The total value of the shares sold amounted to approximately $1,888,748. Ms. Ball's transactions occurred in multiple trades, with prices ranging from $101.62 to $107.00 per share. Following these sales, she no longer holds any shares of Oruka Therapeutics.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
Also reported by 1 other outlet
- Oruka Therapeutics SVP sells $1.05M in shares investing.com
